Offer - Urjas Oil for just ₹ 1
Polycap Capsule (10) is a prescription medicine that is available as a Capsule. Polycap Capsule (10) also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Polycap Capsule (10). Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Polycap Capsule (10) also has some side effects, the most common being Confusion, Cold hands. Some other side effects of Polycap Capsule (10) have been listed ahead. Normally, these side effects of Polycap Capsule (10) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Polycap Capsule (10)'s effect during pregnancy is Severe and Severe while nursing. In addition, Polycap Capsule (10)'s effects on the liver, heart and kidney are discussed below in the Polycap Capsule (10) related warnings section.
Polycap Capsule (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Polycap Capsule (10) in conditions like Liver Disease, Kidney Disease, Alcoholism. Other conditions have been mentioned below in the Polycap Capsule (10) contraindications section.
Drug interactions for Polycap Capsule (10) have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Polycap Capsule (10) is safe while driving, and is addiction.
Polycap Capsule (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Polycap Capsule (10) safe for pregnant women?
Polycap has many dangerous side effects in pregnant women. If you are pregnant, do not consume Polycap without medical advice.
Is the use of Polycap Capsule (10) safe during breastfeeding?
Taking Polycap may lead to serious side effects if you are breastfeeding. Polycap should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Polycap Capsule (10) on the Kidneys?
There can be some harmful effects on your kidneys after taking Polycap. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Polycap Capsule (10) on the Liver?
Polycap is completely safe for the liver.
What is the effect of Polycap Capsule (10) on the Heart?
You may experience side effects on your heart after taking Polycap. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Polycap Capsule (10) unless your doctor advises you to do so -
Is this Polycap Capsule (10) habit forming or addictive?
No, there is no any evidence that Polycap Capsule (10) is addictive.
Interaction between Food and Polycap Capsule (10)
Information is not available on the interaction of any foods with Polycap Capsule (10), due to a lack of research on this.
Interaction between Alcohol and Polycap Capsule (10)
No research has been done on this till date. Therefore, it is not known what the effect of taking Polycap Capsule (10) with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zocor (simvastatin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 377
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
